[{"orgOrder":0,"company":"Joint Child Health Project, Mauritius","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"MAURITIUS","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2013","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Psychiatry\/Psychology","graph2":"Phase II\/ Phase III","graph3":"Joint Child Health Project, Mauritius","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Joint Child Health Project, Mauritius \/ Undisclosed","highestDevelopmentStatusID":"9","companyTruncated":"Joint Child Health Project, Mauritius \/ Undisclosed"},{"orgOrder":0,"company":"Universitaire Ziekenhuizen KU Leuven","sponsor":"KU Leuven | VISTA-Life | Nestle Health Sciences SA","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"BELGIUM","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2018","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Musculoskeletal","graph2":"Undisclosed","graph3":"Universitaire Ziekenhuizen KU Leuven","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Universitaire Ziekenhuizen KU Leuven \/ KU Leuven | VISTA-Life | Nestle Health Sciences SA","highestDevelopmentStatusID":"1","companyTruncated":"Universitaire Ziekenhuizen KU Leuven \/ KU Leuven | VISTA-Life | Nestle Health Sciences SA"},{"orgOrder":0,"company":"Nordlandssykehuset HF","sponsor":"BASF","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"NORWAY","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2013","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase III","graph3":"Nordlandssykehuset HF","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nordlandssykehuset HF \/ PRONOVA BIOPHARMA NORGE AS","highestDevelopmentStatusID":"10","companyTruncated":"Nordlandssykehuset HF \/ PRONOVA BIOPHARMA NORGE AS"},{"orgOrder":0,"company":"Akershus University Hospital","sponsor":"BASF | Pre Diagnostics AS","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"NORWAY","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2019","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Neurology","graph2":"Phase II","graph3":"Akershus University Hospital","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Akershus University Hospital \/ BASF | Pre Diagnostics AS","highestDevelopmentStatusID":"8","companyTruncated":"Akershus University Hospital \/ BASF | Pre Diagnostics AS"},{"orgOrder":0,"company":"Instituto Palacios","sponsor":"Ferrer Internacional","pharmaFlowCategory":"DU","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"SPAIN","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2014","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Phase IV","graph3":"Instituto Palacios","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Instituto Palacios \/ Ferrer Internacional","highestDevelopmentStatusID":"11","companyTruncated":"Instituto Palacios \/ Ferrer Internacional"},{"orgOrder":0,"company":"Universidad Cat\u00f3lica San Antonio de Murcia","sponsor":"Evonik Operations GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"SPAIN","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2022","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Musculoskeletal","graph2":"Undisclosed","graph3":"Universidad Cat\u00f3lica San Antonio de Murcia","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Universidad Cat\u00f3lica San Antonio de Murcia \/ Evonik Operations GmbH","highestDevelopmentStatusID":"1","companyTruncated":"Universidad Cat\u00f3lica San Antonio de Murcia \/ Evonik Operations GmbH"},{"orgOrder":0,"company":"Aston University","sponsor":"TearLab Corporation","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"UNITED KINGDOM","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2015","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Ophthalmology","graph2":"Undisclosed","graph3":"Aston University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Aston University \/ TearLab Corporation","highestDevelopmentStatusID":"1","companyTruncated":"Aston University \/ TearLab Corporation"},{"orgOrder":0,"company":"Northumbria University","sponsor":"BASF","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"UNITED KINGDOM","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2016","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Nutrition and Weight Loss","graph2":"Undisclosed","graph3":"Northumbria University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Northumbria University \/ PRONOVA BIOPHARMA NORGE AS","highestDevelopmentStatusID":"1","companyTruncated":"Northumbria University \/ PRONOVA BIOPHARMA NORGE AS"},{"orgOrder":0,"company":"BASF","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Hepatology (Liver, Pancreatic, Gall Bladder)","country":"NORWAY","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2016","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Hepatology (Liver, Pancreatic, Gall Bladder)","graph2":"Undisclosed","graph3":"BASF","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hepatology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"BASF \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"BASF \/ Nutrasource"},{"orgOrder":0,"company":"DS Biopharma","sponsor":"Nuvothera","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"IRELAND","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2021","type":"Licensing Agreement","leadProduct":"Omega-3","moa":"||PPA-gamma receptor","graph1":"Dermatology","graph2":"Approved FDF","graph3":"DS Biopharma","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"DS Biopharma \/ Nuvothera","highestDevelopmentStatusID":"15","companyTruncated":"DS Biopharma \/ Nuvothera"},{"orgOrder":0,"company":"Eye and Vision Technologies and Research Institute","sponsor":"ZeaVision, Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2012","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Ophthalmology","graph2":"Phase IV","graph3":"Eye and Vision Technologies and Research Institute","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Eye and Vision Technologies and Research Institute \/ ZeaVision, Inc.","highestDevelopmentStatusID":"11","companyTruncated":"Eye and Vision Technologies and Research Institute \/ ZeaVision, Inc."},{"orgOrder":0,"company":"Canadian College of Naturopathic Medicine","sponsor":"McGill University | Netherlands Open University | Massachusetts General Hospital | Ekhagastiftelsen | AquaOmega | Lipid Analytical Laboratories | Mitacs","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"CANADA","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2022","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Psychiatry\/Psychology","graph2":"Phase II","graph3":"Canadian College of Naturopathic Medicine","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Canadian College of Naturopathic Medicine \/ McGill University | Netherlands Open University | Massachusetts General Hospital | Ekhagastiftelsen | AquaOmega | Lipid Analytical Laboratories | Mitacs","highestDevelopmentStatusID":"8","companyTruncated":"Canadian College of Naturopathic Medicine \/ McGill University | Netherlands Open University | Massachusetts General Hospital | Ekhagastiftelsen | AquaOmega | Lipid Analytical Laboratories | Mitacs"},{"orgOrder":0,"company":"Universit\u00e9 de Montr\u00e9al","sponsor":"Neptune Technologies and Bioressources Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"CANADA","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2013","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Neurology","graph2":"Undisclosed","graph3":"Universit\u00e9 de Montr\u00e9al","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Universit\u00e9 de Montr\u00e9al \/ Neptune Technologies and Bioressources Inc.","highestDevelopmentStatusID":"1","companyTruncated":"Universit\u00e9 de Montr\u00e9al \/ Neptune Technologies and Bioressources Inc."},{"orgOrder":0,"company":"McMaster University","sponsor":"Neptune","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"CANADA","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2017","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Nutrition and Weight Loss","graph2":"Undisclosed","graph3":"McMaster University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Oil","sponsorNew":"McMaster University \/ Neptune","highestDevelopmentStatusID":"1","companyTruncated":"McMaster University \/ Neptune"},{"orgOrder":0,"company":"Nature's Way Canada","sponsor":"Centre for Contact Lens Research","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"CANADA","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2017","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Ophthalmology","graph2":"Undisclosed","graph3":"Nature's Way Canada","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nature's Way Canada \/ Centre for Contact Lens Research","highestDevelopmentStatusID":"1","companyTruncated":"Nature's Way Canada \/ Centre for Contact Lens Research"},{"orgOrder":0,"company":"Universit\u00e9 de Sherbrooke","sponsor":"Samuel Fortin, SFC pharma and associate professor UQAR","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"CANADA","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2019","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Universit\u00e9 de Sherbrooke","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Universit\u00e9 de Sherbrooke \/ Samuel Fortin, SFC pharma and associate professor UQAR","highestDevelopmentStatusID":"1","companyTruncated":"Universit\u00e9 de Sherbrooke \/ Samuel Fortin, SFC pharma and associate professor UQAR"},{"orgOrder":0,"company":"Grace Therapeutics","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"CANADA","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2020","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase III","graph3":"Grace Therapeutics","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Grace Therapeutics \/ Undisclosed","highestDevelopmentStatusID":"10","companyTruncated":"Grace Therapeutics \/ Undisclosed"},{"orgOrder":0,"company":"Physician Recommended Nutriceuticals","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2014","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Ophthalmology","graph2":"Phase II\/ Phase III","graph3":"Physician Recommended Nutriceuticals","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Physician Recommended Nutriceuticals \/ Undisclosed","highestDevelopmentStatusID":"9","companyTruncated":"Physician Recommended Nutriceuticals \/ Undisclosed"},{"orgOrder":0,"company":"Physician Recommended Nutriceuticals","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2014","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Ophthalmology","graph2":"Phase II\/ Phase III","graph3":"Physician Recommended Nutriceuticals","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Physician Recommended Nutriceuticals \/ Undisclosed","highestDevelopmentStatusID":"9","companyTruncated":"Physician Recommended Nutriceuticals \/ Undisclosed"},{"orgOrder":0,"company":"Fred Hutchinson Cancer Center","sponsor":"National Institute on Aging | Gansu Provincial Maternal and Child Health Care Hospital | National Center for Complementary and Integrative Health | Office of Research on Women's Health | Nordic Naturals","pharmaFlowCategory":"DU","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2010","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Undisclosed","graph3":"Fred Hutchinson Cancer Center","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Fred Hutchinson Cancer Center \/ National Institute on Aging | Gansu Provincial Maternal and Child Health Care Hospital | National Center for Complementary and Integrative Health | Office of Research on Women's Health | Nordic Naturals","highestDevelopmentStatusID":"1","companyTruncated":"Fred Hutchinson Cancer Center \/ National Institute on Aging | Gansu Provincial Maternal and Child Health Care Hospital | National Center for Complementary and Integrative Health | Office of Research on Women's Health | Nordic Naturals"},{"orgOrder":0,"company":"Mayo Clinic","sponsor":"National Center for Advancing Translational Sciences | National Institute of Diabetes and Digestive and Kidney Diseases | Building Interdisciplinary Research Careers in Women's Health","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2012","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Endocrinology","graph2":"Phase III","graph3":"Mayo Clinic","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Mayo Clinic \/ National Center for Advancing Translational Sciences | National Institute of Diabetes and Digestive and Kidney Diseases | Building Interdisciplinary Research Careers in Women's Health","highestDevelopmentStatusID":"10","companyTruncated":"Mayo Clinic \/ National Center for Advancing Translational Sciences | National Institute of Diabetes and Digestive and Kidney Diseases | Building Interdisciplinary Research Careers in Women's Health"},{"orgOrder":0,"company":"Per Kogner","sponsor":"Smartfish AS","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2014","type":"Inapplicable","leadProduct":"Omega-3","moa":"PPA-gamma receptor","graph1":"Oncology","graph2":"Phase I","graph3":"Per Kogner","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Per Kogner \/ Smartfish AS","highestDevelopmentStatusID":"6","companyTruncated":"Per Kogner \/ Smartfish AS"},{"orgOrder":0,"company":"Hofseth Biocare ASA","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Sleep","country":"NORWAY","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Omega-3","moa":"Undisclosed","graph1":"Sleep","graph2":"Undisclosed","graph3":"Hofseth Biocare ASA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Sleep","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Hofseth Biocare ASA \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Hofseth Biocare ASA \/ Undisclosed"},{"orgOrder":0,"company":"Hofseth Biocare ASA","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"NORWAY","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Omega-3","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Hofseth Biocare ASA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Hofseth Biocare ASA \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Hofseth Biocare ASA \/ Undisclosed"}]
Find Clinical Drug Pipeline Developments & Deals for Omega-3 fatty acids
Details :
Salmon oil is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Supplementation in Healthy Adults.
Details :
Omega-3 is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Generalized Anxiety Disorder.
Details :
Omega-3 is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Joint Diseases.
Details :
Under the terms of the agreement Nuvothera has acquired an option to exclusively licence rights to develop and commercialise EPADILIN® in the United States.
Details :
Acasti Pharma plans to seek FDA guidance prior to unblinding TRILOGY 2 data, which is expected to delay reporting of TRILOGY 2 topline results until calendar Q3, 2020.
Details :
Omega-3 is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Dementia.
Details :
Omega-3 is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Details :
Omega-3 is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Sarcopenia.
Details :
Omega-3 is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Dry Eye Syndromes.
Reset All
